Integral Diagnostics

Integral Diagnostics Net Income

The Net Income of Integral Diagnostics (IDX.AX) as of Nov 5, 2026 is 21.93 M AUD. In the previous year, Net Income was 4.67 M AUD — a change of 369.36% (higher).

Net Income

21.93 MAUD

YoY

369.36%

Last updated:

In 2026, Integral Diagnostics's profit amounted to 21.93 M AUD, a 369.36% increase from the 4.67 M AUD profit recorded in the previous year.

The Integral Diagnostics Net Income history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Net Income
Date
Net Income
Jan 1, 2024
-60.70 M AUD
Jan 1, 2025
4.67 M AUD
Jan 1, 2026
21.93 M AUD
Jan 1, 2027 (e)
41.04 M AUD
Jan 1, 2028 (e)
49.03 M AUD
Jan 1, 2029 (e)
54.10 M AUD
Jan 1, 2030 (e)
63.32 M AUD
Jan 1, 2031 (e)
80.74 M AUD
The Integral Diagnostics Net Income history
YEARNet IncomeYoY
est80.74 MAUD+27.51%
est63.32 MAUD+17.06%
est54.10 MAUD+10.33%
est49.03 MAUD+19.46%
est41.04 MAUD+87.14%
21.93 MAUD+369.36%
4.67 MAUD-107.70%
-60.70 MAUD-342.41%
25.04 MAUD+71.47%
14.60 MAUD-53.30%
31.27 MAUD+35.75%
23.03 MAUD+9.77%
20.98 MAUD+39.15%
15.08 MAUD-2.59%
15.48 MAUD+35.93%
11.39 MAUD+153.07%
4.50 MAUD+31.44%
3.42 MAUD+6.00%
3.23 MAUD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Integral Diagnostics Revenue

Integral Diagnostics Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2024
469.70 M AUD
42.17 M AUD
-60.70 M AUD
Jan 1, 2025
627.22 M AUD
57.53 M AUD
4.67 M AUD
Jan 1, 2026
788.62 M AUD
67.65 M AUD
21.93 M AUD
Jan 1, 2027 (e)
838.77 M AUD
99.05 M AUD
41.04 M AUD
Jan 1, 2028 (e)
885.79 M AUD
110.52 M AUD
49.03 M AUD
Jan 1, 2029 (e)
935.55 M AUD
119.73 M AUD
54.10 M AUD
Jan 1, 2030 (e)
1.00 B AUD
136.88 M AUD
63.32 M AUD
Jan 1, 2031 (e)
1.06 B AUD
0.00 AUD
80.74 M AUD

Integral Diagnostics Margins

Integral Diagnostics stock margins

The Integral Diagnostics margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Integral Diagnostics. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Integral Diagnostics.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2024
95.12 %
8.98 %
-12.92 %
Jan 1, 2025
95.52 %
9.17 %
0.75 %
Jan 1, 2026
21.37 %
8.58 %
2.78 %
Jan 1, 2027 (e)
21.37 %
11.81 %
4.89 %
Jan 1, 2028 (e)
21.37 %
12.48 %
5.54 %
Jan 1, 2029 (e)
21.37 %
12.80 %
5.78 %
Jan 1, 2030 (e)
21.37 %
13.64 %
6.31 %
Jan 1, 2031 (e)
21.37 %
0.00 %
7.65 %

Integral Diagnostics Stock analysis

What does Integral Diagnostics do? Integral Diagnostics Ltd is an Australian company that has been providing medical imaging services for over 25 years. The company was founded in 1994 by Dr. Ian Kadish and a team of radiologists in Perth, Western Australia, offering radiology services to local clinics and hospitals. Over the years, Integral Diagnostics has expanded its services to provide imaging services nationwide. The business model of Integral Diagnostics is to deliver medical imaging to enable doctors and their patients to have a fast and accurate diagnosis. The company offers imaging services for a variety of medical specialties, including radiology, cardiology, obstetrics and gynecology, and neurology. They operate over 49 locations in Australia, many of which are in rural areas where access to medical care may be limited. Integral Diagnostics offers a wide range of products based on medical imaging. These include X-rays, mammography, ultrasound, CT scans, MRI scans, PET scans, and bone density scans. The company takes pride in being one of the few Australian medical imaging companies to offer a complete range of imaging services. Their services are conducted by qualified radiologists specialized in interpreting medical images. Integral Diagnostics also operates clinics for performing diagnostic and therapeutic procedures such as biopsies, drainages, and injections. These procedures are carried out by highly qualified radiologists to provide patients with faster and more accurate diagnoses. Integral Diagnostics is committed to quality assurance and has a comprehensive quality management system that is annually reviewed by independent auditors. The company is accredited by both the Australian Medical Association and the Australian National Accreditation Scheme (NATA). These accreditations recognize the high standards that Integral Diagnostics sets for delivering medical imaging services. One of Integral Diagnostics' recent activities is their use of artificial intelligence (AI) in image interpretation. The company has partnered with MaxQ AI, a leading provider of AI solutions for medical imaging. Through this partnership, Integral Diagnostics doctors can utilize the latest AI tools to improve their patients' diagnoses. Integral Diagnostics is a strong advocate for social justice and is dedicated to supporting disadvantaged communities in Australia. The company has partnered with nonprofit organizations such as the National Breast Cancer Foundation, The Smith Family, and the Friendship Foundation. Overall, Integral Diagnostics has undergone impressive growth over the past 25 years and is now a leading Australian medical imaging company. With a wide range of imaging services and a strong focus on quality and social responsibility, the company is well-positioned to continue its success in the future. Integral Diagnostics is one of the most popular companies on Eulerpool.

Net Income Details

Understanding Integral Diagnostics's Profit Margins

The profit margins of Integral Diagnostics represent the net income earned after deducting all operational expenses, costs, and taxes from the revenue. This figure is a clear indicator of Integral Diagnostics's financial health, operational efficiency, and profitability. Higher profit margins signify better cost management and income generation capabilities.

Year-to-Year Comparison

Evaluating Integral Diagnostics's profit on a yearly basis can offer significant insights into its financial growth, stability, and trends. A consistent increase in profit suggests improved operational efficiency, cost management, or increased revenue, while a decrease may indicate rising costs, declining sales, or operational challenges.

Impact on Investments

Integral Diagnostics's profit figures are critical for investors who are aiming to understand the company's financial standing and future growth prospects. Increased profits often lead to higher stock valuations, boosting investor confidence and attracting more investments.

Interpreting Profit Fluctuations

When Integral Diagnostics’s profit increases, it often indicates enhanced operational efficiency or increased sales. In contrast, a decline in profit can signal operational inefficiencies, increased costs, or competitive pressures, necessitating strategic interventions to boost profitability.

Frequently Asked Questions about Integral Diagnostics stock

Net Income of Integral Diagnostics is 21.93 M AUD in 2026.

Net Income of Integral Diagnostics changed from 4.67 M AUD to 21.93 M AUD, representing a 369.36% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Net Income Integral Diagnostics since 2006 – with annual values, charts, and detailed analysis.

The achievement of a profit is the biggest goal of a company. The profit can be used for distribution or reinvestment. The profit (also called annual surplus or EAT, earnings after taxes) is the positive difference between income and expenses in a period as shown in the income statement. A negative annual surplus is called annual loss. Both performance measures are also combined under the neutral term annual result.

The Net Income is derived from all revenues / sales minus the expenses in the period under review. The following overview clearly shows which positions contribute to the annual surplus and where the differences lie compared to other variants of profit such as EBT, EBIT, and EBITDA.

Net Income's AUD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Net Income's Integral Diagnostics historically and in real time.

The profit in evaluating a stock

History, usage, calculation, and application of earnings in securities trading.

The history of earnings dates back to the beginnings of modern business organization. Since the beginning of industrialization, companies have been established to generate profits, and profits have been considered an essential part of corporate management. In recent years, the importance of earnings for investors has continued to rise, as many investors seek to find stocks that generate solid earnings.

Use of Profits

In securities trading, profits are used to determine the value of a stock. A company that generates profits is considered financially healthy and its stocks are valued higher, while a company that does not generate profits is considered less reliable and therefore receives a lower valuation. Investors can review the profits of each company by examining the relevant documents such as the income statement, the annual financial statements, and the income tax audits.

Calculation of profits

There are several different ways to calculate profits. The simplest way to calculate profits is by calculating net earnings. Net earnings are calculated by subtracting the company's expenses from its revenue. Another way to calculate profits is by calculating operating income. Operating income is calculated by subtracting the company's materials costs and employee wages and salaries from its revenue.

Use of profits

There are many different ways in which investors can use profits when evaluating stocks. One example is calculating the price-to-earnings ratio (P/E ratio). The P/E ratio is the relationship between the price of a stock and the company's earnings. When calculating the P/E ratio, the stock price is divided by the company's earnings. A low P/E value indicates that the stock has a good price-performance ratio, and a high P/E value indicates that the stock has a poor price-performance ratio.

Advantages and disadvantages of using profits

There are many advantages to using earnings in securities trading. Firstly, investors can check the financial health of a company by analyzing earnings. Secondly, investors can make a better decision about the valuation of a stock by calculating the P/E ratio. Thirdly, investors can reduce their risk by choosing stocks with a low P/E ratio.

However, there are also some drawbacks to relying on profits. Firstly, profits can be distorted if a company increases its profits through cost-cutting measures. Secondly, profits can present an inaccurate picture of a company's financial health if they are not calculated correctly. Thirdly, profits may not always be a reliable indicator of a company's future, as they can easily fluctuate.

t('components_kpi_Explanation_34')

Overall, it can be said that profits in securities trading are an important indicator of a company's financial health. Investors can analyze profits to get a better understanding of the company's financial health and make informed decisions about stock valuation. However, there are some disadvantages to using profits as they can sometimes be distorted or inaccurate. Therefore, it is important for investors to be cautious and carefully analyze profits before making a decision to buy or sell stocks.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Integral Diagnostics

All Key Metrics — Integral Diagnostics